(2S,4R)-1-((S)-2-(tert-butyl)-17-(4-(((2-fluoro-3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)methyl)-1H-1,2,3-triazol-1-yl)-6,9,12,15-tetraoxa-3-azaheptadecanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide

ID: ALA5279825

Chembl Id: CHEMBL5279825

Max Phase: Preclinical

Molecular Formula: C57H69FN10O10S

Molecular Weight: 1105.30

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NCCOCCOCCOCCOCCn2cc(CNc3cccc(Cc4c(C)c5ccc(Oc6ncccn6)cc5oc4=O)c3F)nn2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C57H69FN10O10S/c1-36-45-16-15-44(77-56-60-17-8-18-61-56)31-49(45)78-55(72)46(36)29-41-9-7-10-47(50(41)58)62-32-42-33-67(66-65-42)20-22-74-24-26-76-28-27-75-25-23-73-21-19-59-52(57(4,5)6)54(71)68-34-43(69)30-48(68)53(70)64-37(2)39-11-13-40(14-12-39)51-38(3)63-35-79-51/h7-18,31,33,35,37,43,48,52,59,62,69H,19-30,32,34H2,1-6H3,(H,64,70)/t37-,43+,48-,52+/m0/s1

Standard InChI Key:  PNTMCLRWCUWUEW-SMCXORSOSA-N

Alternative Forms

  1. Parent:

    ALA5279825

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1105.30Molecular Weight (Monoisotopic): 1104.4903AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source